Search Results
Search for other papers by Yanli Miao in
Google Scholar
PubMed
Search for other papers by Haojie Qin in
Google Scholar
PubMed
Search for other papers by Yi Zhong in
Google Scholar
PubMed
Search for other papers by Kai Huang in
Google Scholar
PubMed
Search for other papers by Caijun Rao in
Google Scholar
PubMed
asprosin mediated inhibition of adipose browning To uncover the underlying mechanism of the aforementioned observations, we explored whether Nrf2, a crucial antioxidant transcription factor, was involved in the process. Nrf2 is a transcription factor
Search for other papers by Robin Kristófi in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
action. This includes activation of Dicer, iPFK2 and miRNA leading to lower expression of several pro-inflammatory cytokines such as TNF-α and IL-6. AMPK, AMP kinase; ATF3, activating transcription factor 3; ChREBP, carbohydrate-responsive element
Search for other papers by Marion Régnier in
Google Scholar
PubMed
Search for other papers by Matthias Van Hul in
Google Scholar
PubMed
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium
Search for other papers by Claude Knauf in
Google Scholar
PubMed
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium
Search for other papers by Patrice D Cani in
Google Scholar
PubMed
Introduction Obesity is linked with many cardiometabolic risk factors, such as insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Although lowering body weight is effective for alleviating several of these
Search for other papers by Nicole G Barra in
Google Scholar
PubMed
Search for other papers by Fernando F Anhê in
Google Scholar
PubMed
Search for other papers by Joseph F Cavallari in
Google Scholar
PubMed
Search for other papers by Anita M Singh in
Google Scholar
PubMed
Search for other papers by Darryl Y Chan in
Google Scholar
PubMed
Search for other papers by Jonathan D Schertzer in
Google Scholar
PubMed
uptake, and by inhibiting the expression of FOXO transcription factors, gluconeogenic enzymes (phosphoenolpyruvate, glucose-6-phosphatase), and negative regulators of PI3K/Akt signaling like phosphatase and tensin homolog protein (PTEN) ( Cameron et al